
Ken Hoang
Examiner (ID: 2753, Phone: (571)272-8401 , Office: P/2168 )
| Most Active Art Unit | 2168 |
| Art Unit(s) | 2168 |
| Total Applications | 440 |
| Issued Applications | 294 |
| Pending Applications | 50 |
| Abandoned Applications | 103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20777902
[patent_doc_number] => 20260166095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-06-18
[patent_title] => COMPOSITIONS FOR TREATMENT OF GLIOMA AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/531468
[patent_app_country] => US
[patent_app_date] => 2026-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19531468
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/531468 | COMPOSITIONS FOR TREATMENT OF GLIOMA AND USES THEREOF | Feb 4, 2026 | Pending |
Array
(
[id] => 20193824
[patent_doc_number] => 20250270534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => SYSTEM FOR INDUCING MUTATION BASED ON OPTIMIZED ACTIVATION-INDUCED CYTIDINE DEAMINASE
[patent_app_type] => utility
[patent_app_number] => 19/205994
[patent_app_country] => US
[patent_app_date] => 2025-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19205994
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/205994 | System for inducing mutation based on optimized activation-induced cytidine deaminase | May 11, 2025 | Issued |
Array
(
[id] => 20227349
[patent_doc_number] => 12415992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Dioxygenase mutants and use thereof in synthesizing (2S,3R)-3-hydroxypipecolic acid
[patent_app_type] => utility
[patent_app_number] => 19/027003
[patent_app_country] => US
[patent_app_date] => 2025-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 2039
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19027003
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/027003 | Dioxygenase mutants and use thereof in synthesizing (2S,3R)-3-hydroxypipecolic acid | Jan 16, 2025 | Issued |
Array
(
[id] => 20025144
[patent_doc_number] => 20250163366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => LIGILACTOBACILLUS ANIMALIS STRAIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/028457
[patent_app_country] => US
[patent_app_date] => 2025-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19028457
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/028457 | LIGILACTOBACILLUS ANIMALIS STRAIN AND USE THEREOF | Jan 16, 2025 | Abandoned |
Array
(
[id] => 20578482
[patent_doc_number] => 12570724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Preparation method for biosynthesis of human body structural material
[patent_app_type] => utility
[patent_app_number] => 19/005323
[patent_app_country] => US
[patent_app_date] => 2024-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 3097
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19005323
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/005323 | Preparation method for biosynthesis of human body structural material | Dec 29, 2024 | Issued |
Array
(
[id] => 19800568
[patent_doc_number] => 20250066493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA
[patent_app_type] => utility
[patent_app_number] => 18/942174
[patent_app_country] => US
[patent_app_date] => 2024-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18942174
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/942174 | Production of proteins in glutamine-free cell culture media | Nov 7, 2024 | Issued |
Array
(
[id] => 19998702
[patent_doc_number] => 20250136924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => FOOD GRADE BACTERIA AND METHODS FOR REMOVING GLYPHOSATE AND OTHER HARMFUL SUBSTANCES
[patent_app_type] => utility
[patent_app_number] => 18/928580
[patent_app_country] => US
[patent_app_date] => 2024-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18928580
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/928580 | FOOD GRADE BACTERIA AND METHODS FOR REMOVING GLYPHOSATE AND OTHER HARMFUL SUBSTANCES | Oct 27, 2024 | Pending |
Array
(
[id] => 19985046
[patent_doc_number] => 20250123268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => COMPOSITIONS AND METHODS FOR ACCELERATING DEVELOPMENT OF CANCER THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 18/917986
[patent_app_country] => US
[patent_app_date] => 2024-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18917986
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/917986 | COMPOSITIONS AND METHODS FOR ACCELERATING DEVELOPMENT OF CANCER THERAPEUTICS | Oct 15, 2024 | Abandoned |
Array
(
[id] => 19998483
[patent_doc_number] => 20250136705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA
[patent_app_type] => utility
[patent_app_number] => 18/820925
[patent_app_country] => US
[patent_app_date] => 2024-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18820925
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/820925 | PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA | Aug 29, 2024 | Pending |
Array
(
[id] => 19832344
[patent_doc_number] => 20250084130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => ENGINEERED MCP AND PCP PROTEINS AND SYSTEMS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/813643
[patent_app_country] => US
[patent_app_date] => 2024-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18813643
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/813643 | Engineered MCP and PCP proteins and systems and methods thereof | Aug 22, 2024 | Issued |
Array
(
[id] => 20444013
[patent_doc_number] => 20260000727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-01
[patent_title] => METHOD FOR VALORIZATION OF RICE HUSK
[patent_app_type] => utility
[patent_app_number] => 18/754426
[patent_app_country] => US
[patent_app_date] => 2024-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18754426
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/754426 | METHOD FOR VALORIZATION OF RICE HUSK | Jun 25, 2024 | Pending |
Array
(
[id] => 19641247
[patent_doc_number] => 20240415767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => Tattoo Aftercare Sealant Gel
[patent_app_type] => utility
[patent_app_number] => 18/742931
[patent_app_country] => US
[patent_app_date] => 2024-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18742931
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/742931 | Tattoo Aftercare Sealant Gel | Jun 12, 2024 | Pending |
Array
(
[id] => 19745949
[patent_doc_number] => 20250034514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => LACTIPLANTIBACILLUS PLANTARUM EL6 FOR INCREASING FLAVONOID CONTENT, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/665356
[patent_app_country] => US
[patent_app_date] => 2024-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18665356
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/665356 | LACTIPLANTIBACILLUS PLANTARUM EL6 FOR INCREASING FLAVONOID CONTENT, AND USE THEREOF | May 14, 2024 | Abandoned |
Array
(
[id] => 19543395
[patent_doc_number] => 20240360431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => ENGINEERED ALPHA-GALACTOSIDASE A (A-GAL A) PEPTIDES AND FUNCTIONAL VARIANTS THEREOF AND ASSOCIATED METHODS OF TREATING FABRY DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/649917
[patent_app_country] => US
[patent_app_date] => 2024-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18649917
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/649917 | ENGINEERED ALPHA-GALACTOSIDASE A (A-GAL A) PEPTIDES AND FUNCTIONAL VARIANTS THEREOF AND ASSOCIATED METHODS OF TREATING FABRY DISEASE | Apr 28, 2024 | Pending |
Array
(
[id] => 19432534
[patent_doc_number] => 20240301032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => SUBSTRATES COMPRISING ELASTIN-LIKE POLYPEPTIDES AND CALCIUM IONS
[patent_app_type] => utility
[patent_app_number] => 18/434379
[patent_app_country] => US
[patent_app_date] => 2024-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18434379
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/434379 | SUBSTRATES COMPRISING ELASTIN-LIKE POLYPEPTIDES AND CALCIUM IONS | Feb 5, 2024 | Pending |
Array
(
[id] => 19380954
[patent_doc_number] => 20240270824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => HEMOGLOBIN (Hb) RECOMBINANT EXPRESSION VECTOR AND RECOMBINANT ENGINEERING BACTERIUM, AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/405405
[patent_app_country] => US
[patent_app_date] => 2024-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18405405
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/405405 | HEMOGLOBIN (Hb) RECOMBINANT EXPRESSION VECTOR AND RECOMBINANT ENGINEERING BACTERIUM, AND PREPARATION METHOD AND USE THEREOF | Jan 4, 2024 | Pending |
Array
(
[id] => 19265710
[patent_doc_number] => 20240209409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => Method for Secretory Production of Unnatural-Amino-Acid-Containing Protein
[patent_app_type] => utility
[patent_app_number] => 18/401960
[patent_app_country] => US
[patent_app_date] => 2024-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18401960
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/401960 | Method for Secretory Production of Unnatural-Amino-Acid-Containing Protein | Jan 1, 2024 | Pending |
Array
(
[id] => 19389460
[patent_doc_number] => 20240279330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => ERYTHROCYTE-BINDING THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 18/542152
[patent_app_country] => US
[patent_app_date] => 2023-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18542152
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/542152 | ERYTHROCYTE-BINDING THERAPEUTICS | Dec 14, 2023 | Abandoned |
Array
(
[id] => 19067649
[patent_doc_number] => 20240102075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => METHOD FOR QUANTIFYING 25-HYDROXYVITAMIN D, HYDROXYLASE, QUANTIFICATION COMPOSITION, QUANTIFICATION KIT, ELECTRODE, SENSOR CHIP, AND SENSOR
[patent_app_type] => utility
[patent_app_number] => 18/538143
[patent_app_country] => US
[patent_app_date] => 2023-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18538143
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/538143 | METHOD FOR QUANTIFYING 25-HYDROXYVITAMIN D, HYDROXYLASE, QUANTIFICATION COMPOSITION, QUANTIFICATION KIT, ELECTRODE, SENSOR CHIP, AND SENSOR | Dec 12, 2023 | Pending |
Array
(
[id] => 19379188
[patent_doc_number] => 20240269058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => AGAR HYDROLYSIS PRODUCT HAVING HYALURONIDASE INHIBITORY ACTIVITY AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/527564
[patent_app_country] => US
[patent_app_date] => 2023-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18527564
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/527564 | AGAR HYDROLYSIS PRODUCT HAVING HYALURONIDASE INHIBITORY ACTIVITY AND USES THEREOF | Dec 3, 2023 | Pending |